NCT00090909View on ClinicalTrials.gov

Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

March 31, 2005

Conditions
Lymphoma
Interventions
DRUG

cisplatin

DRUG

dexamethasone

DRUG

gemcitabine hydrochloride

Trial Locations (1)

90095-1678

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00090909 - Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter